Citigroup
TNGX icon

Citigroup’s Tango Therapeutics TNGX Stock Holding History

Citigroup’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.2M Sell
88,013
-63,994
-42% -$1.67M ﹤0.01% 2753
2026
Q2 		$4.75M Buy
152,007
+132,374
+674% +$3.27M ﹤0.01% 2187
2026
Q1 		$411K Sell
19,633
-16,603
-46% -$231K ﹤0.01% 3660
2025
Q4 		$321K Buy
36,236
+18,134
+100% +$156K ﹤0.01% 3788
2025
Q3 		$152K Sell
18,102
-12,189
-40% -$82.5K ﹤0.01% 4104
2025
Q2 		$155K Sell
30,291
-11,532
-28% -$28.5K ﹤0.01% 4181
2025
Q1 		$57.3K Sell
41,823
-5,169
-11% -$12.7K ﹤0.01% 4845
2024
Q4 		$145K Buy
46,992
+8,316
+22% +$38.6K ﹤0.01% 4630
2024
Q3 		$298K Buy
38,676
+16,611
+75% +$159K ﹤0.01% 4080
2024
Q2 		$189K Sell
22,065
-169,368
-88% -$1.31M ﹤0.01% 3902
2024
Q1 		$1.52M Buy
191,433
+183,270
+2,245% +$1.96M ﹤0.01% 2672
2023
Q4 		$80.8K Buy
8,163
+6,945
+570% +$60.3K ﹤0.01% 4288
2023
Q3 		$13.7K Sell
1,218
-14,910
-92% -$90.9K ﹤0.01% 4480
2023
Q2 		$53.5K Buy
16,128
+7,937
+97% +$28.6K ﹤0.01% 4605
2023
Q1 		$32.4K Sell
8,191
-2,152
-21% -$12.5K ﹤0.01% 4372
2022
Q4 		$75K Sell
10,343
-1,449
-12% -$10.2K ﹤0.01% 4137
2022
Q3 		$43K Sell
11,792
-1,752
-13% -$7.48K ﹤0.01% 4457
2022
Q2 		$61K Sell
13,544
-23,165
-63% -$140K ﹤0.01% 4455
2022
Q1 		$278K Buy
36,709
+4,267
+13% +$37K ﹤0.01% 3887
2021
Q4 		$355K Buy
32,442
+29,273
+924% +$352K ﹤0.01% 4023
2021
Q3 		$41K Buy
+3,169
New +$38K ﹤0.01% 4844

Other funds holding TNGX

Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Citigroup's TNGX Position: Q3 2026 in Review

Citigroup reduced its Tango Therapeutics (TNGX) stake by 42% in Q3 2026, selling an estimated $1.67M and leaving 88,013 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Citigroup first reported a position in TNGX in Q3 2021 and has held it in 21 quarters since. The position peaked at $4.75M in Q2 2026. 62 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Citigroup held 88,013 shares of Tango Therapeutics worth $2.2M as of Q3 2026.
  • Citigroup sold 63,994 Tango Therapeutics shares in Q3 2026, an estimated $1.67M.
  • Tango Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #2753 holding.
  • Citigroup first reported a position in Tango Therapeutics in Q3 2021 and has held it in 21 quarters since.
  • Citigroup's Tango Therapeutics position peaked at $4.75M in Q2 2026.
  • 62 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.